Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 5
Submit an article Journal homepage
1,399
Views
23
CrossRef citations to date
0
Altmetric
Original Research

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma

Meghan J. MooradianDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAView further author information
,
Alexandre ReubenDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXORCID Iconhttp://orcid.org/0000-0003-4510-0382View further author information
ORCID Icon,
Peter A. PrietoDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXView further author information
,
Mehlika Hazar-RethinamDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAORCID Iconhttp://orcid.org/0000-0002-3619-7250View further author information
ORCID Icon,
Dennie T. FrederickDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MAView further author information
,
Brandon NadresDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAORCID Iconhttp://orcid.org/0000-0002-4690-5978View further author information
ORCID Icon,
Adriano PirisDepartment of Medicine, Harvard Medical School, Boston, MA;Department of Pathology, Massachusetts General Hospital, Boston, MAView further author information
,
Vikram JunejaDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA;Harvard University and Massachusetts Institute of Technology, Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA;Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MAView further author information
,
Zachary A. CooperDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXORCID Iconhttp://orcid.org/0000-0003-1059-0940View further author information
ORCID Icon,
Arlene H. SharpeDepartment of Medicine, Harvard Medical School, Boston, MA;Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA;Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MAView further author information
,
Ryan B. CorcoranDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAView further author information
,
Keith T. FlahertyDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAView further author information
,
Donald P. LawrenceDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MAView further author information
,
Jennifer A. WargoDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXView further author information
&
Ryan J. SullivanDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA;Department of Medicine, Harvard Medical School, Boston, MA;Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TXCorrespondence[email protected]
View further author information
 show all
Article: e1423172 | Received 10 Oct 2017, Accepted 22 Dec 2017, Published online: 01 Feb 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.